HG-7-85-01
HG-7-85-01 is a type II ATP competitive inhibitor of wild-type and gatekeeper mutations forms of Bcr-Abl, PDGFRα, Kit, and Src kinases. HG-7-85-01 inhibits T315I mutant Bcr-Abl kinase, KDR and RET with IC50s of 3 nM, 20 nM and 30 nM, and is only weak or no inhibition of other kinases (IC50>2 μM) . HG-7-85-01 inhibits the cell proliferation, which is mediated by the induction of apoptosis, and inhibition of cell-cycle progression[1].
Product Specifications
CAS Number
1258391-13-7
UNSPSC
12352005
Target
Apoptosis; Bcr-Abl; c-Kit; JAK; PDGFR; Src
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hg-7-85-01.html
Purity
99.94
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(CN2CCN(CC)CC2)C(C(F)(F)F)=C1)C3=CC=CC(C4=CC=C5C(SC(NC(C6CC6)=O)=N5)=N4)=C3
Molecular Formula
C31H31F3N6O2S
Molecular Weight
608.68
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bcr-Abl; JAK1; PDGFRα
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
(R)-3-(4-Chlorophenyl)-4-hydroxybutyric Acid Sodium Salt
![PARG Mouse Monoclonal Antibody [Clone ID: OTI9F6]](https://cdn.genprice.uk/products/937/68dd18ba061270361e9083be/imageurl/cf808712.webp)